Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Journey Medical Corporation (DERM)
Last journey medical corporation earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.dermira.com
Company Research
Source: Yahoo! Finance
Net Product Revenue Growth: 11% for the full year 2025. Gross Margin: Improved to 66.2% from 62.8% in 2024. SG&A Expenses: $44.4 million, up 10% from $40.2 million in 2024. GAAP Net Loss: $11.4 million or $0.47 per share, compared to $14.7 million or $0.72 per share in 2024. Adjusted EBITDA: Positive $2.9 million, up from $800,000 in 2024. Cash Position: $24.1 million at year-end, up from $20.3 million in 2024. Working Capital: $29.4 million, an increase from $13 million in the previous year. MROS Net Sales: $14.7 million during the three quarters of 2025. MROS Prescriptions: Approximately 53,000 total prescriptions in 2025. Unique Prescribers for MROS: Over 3,500 dermatology prescribers by the end of 2025. Warning! GuruFocus has detected 4 Warning Signs with DERM. Is DERM fairly valued? Test your thesis with our free DCF calculator. Release Date: March 25, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcri
Show less
Read more
Impact Snapshot
Event Time:
DERM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DERM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DERM alerts
High impacting Journey Medical Corporation news events
Weekly update
A roundup of the hottest topics
DERM
News
- Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Journey Medical (DERM) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.MarketBeat
- Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 [Yahoo! Finance]Yahoo! Finance
DERM
Earnings
- 3/25/26 - Beat
DERM
Analyst Actions
- 3/26/26 - HC Wainwright
DERM
Sec Filings
- 3/26/26 - Form 10-K
- 3/25/26 - Form 8-K
- 1/23/26 - Form 424B3
- DERM's page on the SEC website